Insulin Delivery Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update
Summary
GlobalData's Medical Devices sector report, “Insulin Delivery Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update provides comprehensive information about the Insulin Delivery pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Insulin delivery devices are used to inject measured doses of insulin through the skin and into the fatty tissues below.
Note:Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
Extensive coverage of the Insulin Delivery under development
The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
The report reviews the major players involved in the development of Insulin Delivery and list all their pipeline projects
The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
The report provides key clinical trial data of ongoing trials specific to pipeline products
Recent developments in the segment / industry
Reasons to Buy
The report enables you to -
Formulate significant competitor information, analysis, and insights to improve R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
Identify and understand important and diverse types of Insulin Delivery under development
Develop market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
In-depth analysis of the product’s current stage of development, territory and estimated launch date
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Insulin Delivery Overview
3 Products under Development
3.1 Insulin Delivery - Pipeline Products by Stage of Development
3.2 Insulin Delivery - Pipeline Products by Segment
3.3 Insulin Delivery - Pipeline Products by Territory
3.4 Insulin Delivery - Pipeline Products by Regulatory Path
3.5 Insulin Delivery - Pipeline Products by Estimated Approval Date
3.6 Insulin Delivery - Ongoing Clinical Trials
4 Insulin Delivery - Pipeline Products under Development by Companies
4.1 Insulin Delivery Companies - Pipeline Products by Stage of Development
4.2 Insulin Delivery - Pipeline Products by Stage of Development
5 Insulin Delivery Companies and Product Overview
6 Insulin Delivery- Recent Developments
7 Appendix
7.1 Methodology
7.2 About GlobalData
7.3 Contact Us
7.4 Disclaimer
List of Tables
Insulin Delivery - Pipeline Products by Stage of Development
Insulin Delivery - Pipeline Products by Segment
Insulin Delivery - Pipeline Products by Territory
Insulin Delivery - Pipeline Products by Regulatory Path
Insulin Delivery - Pipeline Products by Estimated Approval Date
Insulin Delivery - Ongoing Clinical Trials
Insulin Delivery Companies - Pipeline Products by Stage of Development
Insulin Delivery - Pipeline Products by Stage of Development
Wireless Insulin Pump System Integrated With inControl AP - Product Status
Wireless Insulin Pump System Integrated With inControl AP - Product Description
Companion Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
Smart Insulin Pen - Advanced Decision Support - Product Status
Smart Insulin Pen - Advanced Decision Support - Product Description
Debiotech SA Pipeline Products & Ongoing Clinical Trials Overview
JewelPump - Product Status
JewelPump - Product Description
JewelPUMP2 - Product Status
JewelPUMP2 - Product Description
Defymed SAS Pipeline Products & Ongoing Clinical Trials Overview
ExOlin - Product Status
ExOlin - Product Description
Defymed SAS - Ongoing Clinical Trials Overview
ExOlin - An Open Label, Monocentric, Pilot Study Evaluating Safety of ExOlin in Patients with Poorly Controlled Type 1 Diabetes with High Glucose Fluctuations, Prone to Severe Hypoglycemia
Diabeloop SA Pipeline Products & Ongoing Clinical Trials Overview
DBL-4pen - Product Status
DBL-4pen - Product Description
Diabeloop SA - Ongoing Clinical Trials Overview
DBL-4pen - Multicentric Before/After Study to Assess the Efficacy and Safety of DBL-4pen Mobile Application on Glycemic Control in Patients With Type 2 Diabetes
Eli Lilly and Co Pipeline Products & Ongoing Clinical Trials Overview
AIR Insulin System - Product Status
AIR Insulin System - Product Description
Connected Care Pre-Filled Insulin Pen - Product Status
Connected Care Pre-Filled Insulin Pen - Product Description
Tubed Patch Pump With T2D Insulin Control Algorithm - Product Status
Tubed Patch Pump With T2D Insulin Control Algorithm - Product Description
Tubeless Patch Pump With T2D Insulin Control Algorithm - Product Status
Tubeless Patch Pump With T2D Insulin Control Algorithm - Product Description
Embecta Corp - Ongoing Clinical Trials Overview
Closed-Loop Patch Pump with Insulin-Dosing Algorithm - A Randomized, Controlled, Crossover Trial to Assess a Fully Automated, Dual-hormone (Insulin-and-pramlintide) Delivery System Without Carbohydrate Counting in Regulating Glucose Levels in Adults With Type 1 Diabetes.
Spring Health Solutions Ltd. Pipeline Products & Ongoing Clinical Trials Overview
Spring Zone Hybrid Patch Pump - Product Status
Spring Zone Hybrid Patch Pump - Product Description
Tandem Diabetes Care Inc Pipeline Products & Ongoing Clinical Trials Overview
CSII Catheter - Product Status
CSII Catheter - Product Description
SteadiSet Infusion Set - Product Status
SteadiSet Infusion Set - Product Description
t:slim X3 Insulin Pump - Product Status
t:slim X3 Insulin Pump - Product Description
Tandem Mobi: Tubeless - Product Status
Tandem Mobi: Tubeless - Product Description
Tandem Patch - Product Status
Tandem Patch - Product Description
Tandem Diabetes Care Inc - Ongoing Clinical Trials Overview
CSII Catheter - A Pilot Study for the Systematic Evaluation of the Inflammatory Response to Commercially Available Insulin Infusion Catheters in Subcutaneous Adipose Tissue
SteadiSet Infusion Set - Open, Single Arm, Prospective, Multicenter Study of an Investigational Extended Wear Insulin Infusion Set During Home Use in People with Type 1 Diabetes
TempraMed Israel Ltd Pipeline Products & Ongoing Clinical Trials Overview